ATYR aTyr Year-over-year net earnings per share growth for the last 12 months
This quarterly earnings per share chart demonstrates the financial resilience of aTyr Pharma, Inc. (ATYR), while the 30.20 metric reflects current dynamics. The company's revenues are based on the implementation of immunotherapy and the development of antibodies to combat sarcoidosis. Patents on enzymes provide a technological moat, although high competition in the autoimmune pathology niche creates certain market risks.
ATYR (aTyr Pharma): analytical breakdowns and indicator data
- market value and analyst target forecast:
- market capitalization data:
- book capitalization indicators:
- debt and liquidity data:
- earnings and market multiples details:
ATYR - Final Profit|Expected Profit aTyr Pharma, Inc.|ATYR - Market Cap to Net Income|Forward P/E Multiple aTyr Pharma, Inc.|ATYR - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple aTyr Pharmaceuticals|ATYR - Operating profit EBITDA|Earnings per share for the last twelve months aTyr Pharma|ATYR - Earnings per share for the trailing year|Year-over-year earnings per share growth for the last twelve months atyrpharma.com|ATYR - Net earnings per share growth this year|Earnings growth forecast for next year aTyr Pharma, Inc.
- company sales and revenue statistics:
Fundamental company valuation:atyrpharma.com, ATYR
For aTyr Pharma, Inc. (ATYR), which automates the synthesis of anti-inflammatory agents, the quarterly earnings per share trend reflects the efficiency of capital expenditures against the backdrop of prolonged clinical trials. This indicator measures the percentage change in net income per share relative to the previous quarter, allowing investors to distinguish genuine financial growth from speculative asset overvaluation.
Analysis of competing companies
argenx BVBA (ARGX) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share growth for the last 12 months BioNTech SE|Year-over-year net earnings per share growth for the last 12 months ABVX|Quarterly EPS earnings growth admabiologics.com|Year-over-year earnings per share growth for the last twelve months Protagonist Therapeutics Inc (PTGX)|Immunovant - Year-over-year earnings per share growth for the last 12 months|Quarterly EPS earnings growth KNSA (kiniksa.com)|Grifols Group (GRFS) - Earnings per share growth in annualized terms for the last twelve months|Adaptive Biotechnologies Inc. - Quarterly EPS earnings growth|Celldex Therapeutics (CLDX) - Year-over-year net earnings per share growth for the last 12 months|AUPH (auriniapharma.com) - Year-over-year net earnings per share growth for the last 12 months|BCRX - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Vera Pharma|Quarterly EPS earnings growth Dianthus Corp|Year-over-year earnings per share growth for the last twelve months Pharvaris N.V. (PHVS)|ABCL - Earnings per share growth in annualized terms for the last twelve months|Year-over-year earnings per share growth for the last twelve months Tourmaline Bio Inc TRML|Year-over-year net earnings per share change for the last twelve months Precigen (PGEN)|Pharming Corp - Quarterly EPS earnings growth|Year-over-year earnings per one share growth for the last 12 months NKTR (Nektar Therapeutics)|upstreambio.com (UPB) - Year-over-year earnings per share growth for the last twelve months|ZBIO (Zenas Biopharma Inc) - Year-over-year earnings per share growth for the last twelve months|IMNM (Immunome Bio) - Quarterly EPS earnings growth|GOSS: Year-over-year earnings per one share growth for the last 12 months|Year-over-year net earnings per share growth for the last 12 months KALV (KalVista Pharmaceuticals Inc)|SEPN (Septerna Corp) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth PVLA (Pieris Corp)|SVRA - Year-over-year net earnings per share growth for the last 12 months|RIGL - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per one share growth for the last 12 months ANAB (AnaptysBio)|ATXS: Quarterly EPS earnings growth|ENGN - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months RAPT|JBIO: Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Aclaris Therapeutics (ACRS)|KYTX: Year-over-year net earnings per share trend for the last twelve months|Quarterly EPS earnings growth TLSA (Tiziana Life Sciences, Ltd.)|Year-over-year net earnings per share change for the last twelve months Cabaletta Bio Inc (CABA)|ventyxbio.com - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months theratech.com|AVTX: Quarterly EPS earnings growth|ELDN: Year-over-year earnings per share growth rate for the last twelve months|AGEN (Agenus, Inc) - Quarterly EPS earnings growth|Climb Bio, Inc. - Year-over-year net earnings per share trend for the last twelve months|Year-over-year earnings per share growth for the last twelve months Zura Bio (ZURA)|Year-over-year net earnings per share change for the last twelve months Adagene Inc|Year-over-year earnings per share growth for the last twelve months ImageneBio Inc IMA|Year-over-year earnings per share growth rate for the last twelve months STTK (shattucklabs.com)|EQ: Year-over-year net earnings per share growth for the last 12 months|CNTB: Year-over-year earnings per share growth for the last twelve months|IMUX: Quarterly EPS earnings growth|Atara Biotherapeutics (ATRA) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months IFRX|Quarterly EPS earnings growth X4 Pharmaceuticals Inc.|Year-over-year earnings per share growth for the last twelve months Adicet Bio Inc. (ACET)|Year-over-year net earnings per share growth for the last 12 months Celularity CELU|Quarterly EPS earnings growth INMB (INmune Bio Corporation)|Year-over-year net earnings per share change for the last twelve months Barinthus Biotherapeutics (BRNS)|KZR - Year-over-year earnings per share growth for the last twelve months|SABS - Quarterly EPS earnings growth|Akari Therapeutics, Plc (AKTX) - Year-over-year earnings per share growth for the last twelve months|Enlivex Therapeutics, Ltd. (ENLV) - Quarterly EPS earnings growth|QTTB (Q32 Bio Inc) - Quarterly EPS earnings growth|geovax.com (GOVX) - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months EDSA (Edesa Biotech)|Year-over-year net earnings per share change for the last twelve months iBio Inc|Quarterly EPS earnings growth CARM (Carisma Therapeutics Inc)|Year-over-year earnings per one share growth for the last 12 months XTLB|BOLT: Year-over-year net earnings per share growth for the last 12 months|HCW Biologics (HCWB) - Year-over-year net earnings per share growth for the last 12 months|Aptevo (APVO) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share growth for the last 12 months AIM ImmunoTech|Year-over-year net earnings per share growth for the last 12 months ADTX|GRI Bio Corporation (GRI) - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months XRTX (XORTX Therapeutics Inc.)|Vyome Holdings Inc - Year-over-year earnings per share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Revelation Biosciences Inc REVB|INDP - Year-over-year net earnings per share growth for the last 12 months|SCNI: Year-over-year net earnings per share growth for the last 12 months|CALI: Year-over-year earnings per share growth for the last twelve months|AFMD: Quarterly EPS earnings growth|Allakos Inc - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months HOOKIPA Pharma, Inc.|IGM Biosciences, Inc. (IGMS) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months iteostherapeutics.com (ITOS)|OCEA - Earnings per share growth in annualized terms for the last twelve months|TC BioPharm (Holdings) PLC - Year-over-year net earnings per share growth for the last 12 months|THRD: Year-over-year earnings per share growth for the last 12 months
